Aldosterone Blockade in Patients With Systolic Left Ventricular Dysfunction-Reference-Cited by-同舟云学术

Aldosterone Blockade in Patients With Systolic Left Ventricular Dysfunction

Published:2003-10-14 Issue:15 Volume:108 Page:1790-1794
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Pitt Bertram¹

Affiliation:

1. From the University of Michigan School of Medicine, Ann Arbor, Mich.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000086776.15268.22

Reference27 articles.

1. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

2. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

3. Clinical implications of aldosterone blockade

4. Pitt B Reichek N Metscher B et al. Efficacy and safety of eplerenone enalapril and eplerenone/enalapril combination therapy in patients with left ventricular hypertrophy. Circulation . In press.

5. Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary Artery Disease: From Mechanism to Clinical Practice;Advances in Experimental Medicine and Biology;2020

2. Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association;Circulation;2017-09-26

3. Inhibitors of the renin-angiotensin-aldosterone system;Drugs for the Heart;2013

4. Diuretics;Drugs for the Heart;2013

5. Heart Failure in Hypertension;Hypertension: A Companion to Braunwald’s Heart Disease;2013